Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 4Breast 3Genitourinary 2Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Prostatic Neoplasms 1Erectile Dysfunction 1Carcinoma, Renal Cell 1

Interventions

Docetaxel 77Radiotherapy 73Prednisone 65Leuprolide 51Goserelin 49Gemcitabine 49Cisplatin 48bicalutamide 46enzalutamide 41Androgen Antagonists 36pembrolizumab 32Abiraterone Acetate 30Mitomycin 29acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 28Magnetic Resonance Spectroscopy 28Carboplatin 27Flutamide 25Triptorelin Pamoate 23Sunitinib 23Nivolumab 23Radiation 22apalutamide 21Doxorubicin 20darolutamide 18Gonadotropin-Releasing Hormone 18cabozantinib 16abiraterone 16Specimen Handling 16Radiosurgery 16Paclitaxel 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Tablets × Genitourinary × Clear all
NCT01865747 2021-04-27

METEOR

Exelixis

Phase 3 Completed
658 enrolled 15 charts
Genitourinary

Carcinoma, Renal Cell

NCT03406169 2018-01-23

Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy

Brooke Army Medical Center

Phase 3 Unknown
180 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡